Brief: Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

CDT Equity

16/07/2024 12:31

July 16 (Reuters) - Conduit Pharmaceuticals Inc  CDT.O :
    * CONDUIT PHARMACEUTICALS RECEIVES PATENT APPROVAL FOR ITS
LEAD
ASSET TARGETING AUTOIMMUNE DISEASES

Source text for Eikon:  ID:nGNX5XXWc9 
Further company coverage:  CDT.O 

 ((Reuters.Briefs@thomsonreuters.com;))